DOI: 10.1007/978-3-319-55107-4_2
关键词:
摘要: The discovery and progress in the field of endothelial progenitor cells (EPCs) are leading numerous researchers to discuss applying them as potential predictive, diagnostic prognostic biomarkers age-related diseases order improve prevention, management outcome such diseases. However, growing evidence suggests changes number functions EPCs significantly associated with cardiovascular diseases, diabetes, Alzheimer’s disease, cancer complications. In addition, have been suggested therapeutic agents for many these Certainly, aspects remain be clarified, controversies must verified eliminated. As a result, road is still hard long, but advances obtained may offer us greater unique opportunities meet considerable challenge